ZVRA compared with SCYX: revenue, margins and what each company keeps, and the suppliers and customers both name

ZVRAZevra Therapeutics, Inc.

Mkt capRevenueRevenue

SCYXScynexis Inc

Mkt capRevenueRevenue

Compare

ZVRAZevra Therapeutics, Inc.

SCYXScynexis Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ZVRA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±13.4%▲+12.82%×0.96

May 7 '26±13.3%▼−2.22%×0.17

Q1 FY26±29.2%▲+21.27%×0.73

Q3 FY25±14.7%▼−9.73%×0.66

SCYX

No earnings history for SCYX.

= impliedZVRA realized, solidSCYX realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

ZVRAZevra Therapeutics, Inc.

10.08· pre 9.98· delayed

Mkt cap$599.8MRevenue$40MQ2 FY26Revenue$106MFY25

SCYXScynexis Inc

3.78· pre 3.84· delayed

Pre-marketNov 2 '26delayed

Mkt cap$37.5MRevenue$235,000Q2 FY26Revenue$21MFY25

Compare

Pre-marketNov 2 '26delayed

ZVRAZevra Therapeutics, Inc.

SCYXScynexis Inc

10.08pre 9.98delayed

Price

3.78pre 3.84delayed

$599.8M

Mkt cap

$37.5M

Q2 FY26$40M

Revenue

$235,000Q2 FY26

FY25$106M

Revenue

$21MFY25

ZVRA10.08vsSCYX3.78Pre-marketNov 2 '26delayed